News & Media
IRVINE, Calif. – December 20, 2017 – AIVITA Biomedical today announced that the first patient has been enrolled in its double-blind Phase II clinical study assessing the efficacy and safety of its autologous cancer immunotherapy…Read More
IRVINE, Calif. – December 07, 2017 – AIVITA Biomedical today announced the execution of a deal with custom formulator and beauty product developer Lacore Laboratories. The deal allows for the use of AIVITA’s proprietary actives…Read More
IRVINE, Calif. – November 6, 2017 – AIVITA Biomedical CEO Dr. Hans Keirstead is scheduled to speak at Exponential Medicine, a biomedical and technology conference taking place November 6-9 at the Hotel del Coronado in…Read More
IRVINE, Calif. – September 21, 2017 – AIVITA Biomedical, a clinical research company and commercial skincare product developer, announced today that internationally-known dermatologist and cosmetic surgeon Dr. Michael H. Gold has joined its Scientific Advisory…Read More
IRVINE, Calif. September 19, 2017 – AIVITA Biomedical today announced the discovery of a new method for capturing and using intercellular signaling molecules to induce the reactivation of stem cell niches. The implication of this…Read More
IRVINE, C.A., June 13, 2017 – AIVITA Biomedical offered its congratulations today following the announcement of positive 9-month efficacy and safety data from Asterias Biotherapeutics’ SCiStar Phase 1/2a clinical study for patients with complete…Read More
IRVINE, Calif. – June 7, 2017 – AIVITA Biomedical today announced that Chief Executive Officer Hans Keirstead, Ph.D. will be speaking at the upcoming Stem Cell Cures Consortium Conference. The conference, taking place June 8th…Read More
IRVINE, Calif. – May 3, 2017– AIVITA Biomedical today announced the appointment of operations executive Ed Inal as Chief Operating Officer. In this role Inal will oversee the day-to-day operations of AIVITA’s therapeutic pipeline…Read More
IRVINE, Calif. – May 2, 2017 – AIVITA Biomedical today announced that it will be appearing at the upcoming Music City SCALE Symposium for Cosmetic Advances & Laser Education in Nashville, Tennessee. The conference, taking…Read More
IRVINE, Calif. – April 3, 2017 – AIVITA Biomedical today announced that Chief Executive Officer Hans Keirstead, Ph.D. will be speaking at the upcoming Stem Cell Summit in Boston, Massachusetts. The conference, taking place April…Read More
IRVINE, Calif. – February 7, 2017 – AIVITA Biomedical today announced it will present details of its patented skin care technology and commercial line of skin care products at the upcoming South Beach Symposium…Read More
IRVINE, Calif. – February 2, 2017 – AIVITA Biomedical today announced the launch of PROVOQUETM Eye Complex, a patented stem cell-derived formula that helps address the visible signs of skin aging under and around…Read More
IRVINE, Calif. – September 29, 2016 – AIVITA Biomedical, a stem cell company with clinical and commercial programs, today announced that the National Eye Institute of the National Institute of Health (NIH) has awarded…Read More
IRVINE, Calif. – September 20, 2016 – AiVita Biomedical today announced that it will present details on its autologous cancer immunotherapy, subject of an upcoming Phase II clinical trial in ovarian cancer, at the National Center…Read More
IRVINE, C.A., September 13, 2016 – AiVita CEO and neuroscientist Dr. Hans Keirstead offered his congratulations today for milestones reached in Asterias Biotherapeutics’ Phase 1 and Phase 1/2a clinical studies for newly injured patients…Read More
IRVINE, C.A., July 7, 2016 – AiVita Biomedical, a Southern California-based therapeutic development company, today announced that the California Institute for Regenerative Medicine (CIRM) has approved the Company to collaborate on an early translational…Read More
IRVINE, C.A., June 21, 2016 – AiVita Biomedical, a therapeutic development company focused on regenerative and curative medicines, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s Investigational New…Read More
IRVINE, C.A., June 10, 2016 — AiVita Biomedical, a therapeutic development company focused on regenerative and curative medicines, today announced it has completed a $2 million Series A round of equity investment. The capital comes…Read More
Dr. Hans Keirstead Speaks at Exponential Medicine 2017
November 7 2017 – by Singularity University
Dr. Hans Keirstead speaks at Exponential Medicine 2017 providing an overview of the stem cell sector and highlighting recent advancements by AIVITA Biomedical.
Cutting Edge Ingredients
September 2017 – by MedEsthetics Magazine
MedEsthetics Magazine covers the latest exciting new skincare products and ingredients, including the PROVOQUETM line of skincare products.
First Paralyzed Human Regains His Upper Body Movement After Being Treated With Stem Cells
July 4 2017 – by The Power of Ideas, Ideapod Blog
Acute spinal cord injury patient in Asterias Biotherapeutics’ SCiStar trial regains upper body movement after being treated with doses of AST-OPC1 cells.
May/June 2017 – Wendy Lewis, PRIME International Journal of Aesthetic and Anti-Aging Medicine
Wendy Lewis takes a deep dive into the professional skin care market and what’s driving new launches and consumer demands.
May/June 2017 – Nora Burba Trulsson and Lauren Swanson, Modern Luxury Scottsdale
Modern Luxury Scottsdale speaks with local philanthropist Vicki Vaughn to discuss her must-haves for staying gorgeous inside and out, including PROVOQUE® Eye Complex.
Diabetes Cure: Could You Eventually Stop Pills and Insulin
May 17, 2017 – David Nazar, PBS
Millions of people suffer from diabetes. Until now the treatment has been pills or insulin. However, scientists have made a phenomenal new discovery using stem cells to eventually cure diabetes. PBS reporter David Nazar discusses clinical trials with renowned expert Dr. Hans Keirstead.
Can new supplements, serum repair skin from the inside and outside?
April 03, 2017 – Meg Farris, WWLTV
WWLTV New Orleans speaks with dermatologist Dr. Mary Lupo about the latest in skin care and the regimen she employs at her practice, which includes the use of PROVOQUE® following laser treatment.
Human stem cells successfully restore the skin stem cell niche, rejuvenate skin
February 10, 2017 – Healio
Healio reports on a CME (continuing medical education) presentation given by AIVITA Chief Science Officer Dr. Gabriel Nistor at the 2017 South Beach Symposium. In his talk, Dr. Nistor highlighted new findings concerning the use of skin stem cell factors for skin rejuvenation.